---
title: "CME Group Inc. Reports Record Financial Performance for 2024"
date: "2025-02-12 20:15:00"
summary: "CME Group Inc., a leading derivatives marketplace, has released its financial results for the fourth quarter and full year of 2024. The company has achieved record-breaking figures in several key financial metrics, reflecting robust performance across its various business segments. Financial Highlights For the full year of 2024, CME Group..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

CME Group Inc., a leading derivatives marketplace, has released its financial results for the fourth quarter and full year of 2024. The company has achieved record-breaking figures in several key financial metrics, reflecting robust performance across its various business segments.

**Financial Highlights**

For the full year of 2024, CME Group reported a record revenue of $6.1 billion, marking a 10% increase from the previous year. The company's operating income for the year was $3.9 billion, while net income reached $3.5 billion. On an adjusted basis, net income was $3.7 billion, and diluted earnings per share (EPS) were $10.26.

In the fourth quarter of 2024, CME Group reported revenue of $1.5 billion and operating income of $947 million. Net income for the quarter was $875 million, with diluted EPS of $2.40. Adjusted net income for the quarter was $919 million, and adjusted diluted EPS was $2.52.

**Business and Operational Highlights**

The company experienced significant growth in trading volumes across all asset classes. Fourth-quarter 2024 average daily volume (ADV) was 25.5 million contracts, consistent with the same period in 2023. Notably, non-U.S. ADV increased by 5% to 7.6 million contracts.

Clearing and transaction fees revenue for the fourth quarter totaled $1.2 billion, with a total average rate per contract of $0.701. Market data revenue for the quarter was $182 million.

**Strategic Initiatives and Corporate Developments**

During 2024, CME Group declared dividends totaling $3.8 billion, including an annual variable dividend of $2.1 billion. The company has returned over $28 billion to shareholders since the implementation of its variable dividend policy in 2012. Additionally, CME Group declared a first-quarter dividend of $1.25 per share for 2025, a 9% increase from the previous level.

As of December 31,Â 2024, CME Group had approximately $3.1 billion in cash and $3.4 billion in debt. The company continues to focus on maintaining a strong balance sheet and returning value to shareholders.

**Management's Perspective**

Terry Duffy, CME Group Chairman and Chief Executive Officer, commented on the company's performance: "In 2024, CME Group had its best year ever, generating record annual average daily volume, revenue, adjusted operating income, adjusted net income, and adjusted earnings per share. With volume growth across every asset class, we hit new records in interest rates, including U.S. Treasury and SOFR complexes, as well as in agricultural, foreign exchange, and metals markets."

Duffy also highlighted the company's strong fourth-quarter performance and its commitment to serving global clients amid economic and geopolitical uncertainty.

**Future Outlook**

Looking ahead, CME Group aims to continue providing products, services, and efficiencies that help clients manage risk and pursue business opportunities. The company remains focused on expanding its global reach and maintaining its leadership position in the derivatives marketplace.

SEC Filing: [CME GROUP INC. [ CME ] - 8-K - Feb. 12, 2025](https://www.sec.gov/Archives/edgar/data/1156375/000115637525000007/cme-20250212.htm)

[TradingView](https://www.tradingview.com/news/tradingview:b6f1bb0104a00:0-cme-group-inc-reports-record-financial-performance-for-2024/)
